Literature DB >> 23194041

In vivo optical coherence tomography: the role of the pathologist.

Lida P Hariri1, Mari Mino-Kenudson, Eugene J Mark, Melissa J Suter.   

Abstract

Optical coherence tomography (OCT) is a nondestructive, high-resolution imaging modality, providing cross-sectional, architectural images at near histologic resolutions, with penetration depths up to a few millimeters. Optical frequency domain imaging is a second-generation OCT technology that has equally high resolution with significantly increased image acquisition speeds and allows for large area, high-resolution tissue assessments. These features make OCT and optical frequency domain imaging ideal imaging techniques for surface and endoscopic imaging, specifically when tissue is unsafe to obtain and/or suffers from biopsy sampling error. This review focuses on the clinical impact of OCT in coronary, esophageal, and pulmonary imaging and the role of the pathologist in interpreting high-resolution OCT images as a complement to standard tissue pathology.

Mesh:

Year:  2012        PMID: 23194041     DOI: 10.5858/arpa.2012-0252-SA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Needle-based Optical Coherence Tomography to Guide Transbronchial Lymph Node Biopsy.

Authors:  Eugene Shostak; Lida P Hariri; George Z Cheng; David C Adams; Melissa J Suter
Journal:  J Bronchology Interv Pulmonol       Date:  2018-07

2.  Diagnosing lung carcinomas with optical coherence tomography.

Authors:  Lida P Hariri; Mari Mino-Kenudson; Michael Lanuti; Alyssa J Miller; Eugene J Mark; Melissa J Suter
Journal:  Ann Am Thorac Soc       Date:  2015-02

3.  Swept-Source Anatomic Optical Coherence Elastography of Porcine Trachea.

Authors:  Ruofei Bu; Hillel Price; Sorin Mitran; Carlton Zdanski; Amy L Oldenburg
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016

4.  Quantitative assessment of airway remodelling and response to allergen in asthma.

Authors:  David C Adams; Alyssa J Miller; Matthew B Applegate; Josalyn L Cho; Daniel L Hamilos; Alex Chee; Jasmin A Holz; Margit V Szabari; Lida P Hariri; R Scott Harris; Jason W Griffith; Andrew D Luster; Benjamin D Medoff; Melissa J Suter
Journal:  Respirology       Date:  2019-03-07       Impact factor: 6.424

5.  Beyond isolated cells: microfluidic transport of large tissue for pancreatic cancer diagnosis.

Authors:  Ronnie Das; Rachel G Murphy; Eric J Seibel
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-05

6.  Intraoperative optical coherence tomography for assessing human lymph nodes for metastatic cancer.

Authors:  Ryan M Nolan; Steven G Adie; Marina Marjanovic; Eric J Chaney; Fredrick A South; Guillermo L Monroy; Nathan D Shemonski; Sarah J Erickson-Bhatt; Ryan L Shelton; Andrew J Bower; Douglas G Simpson; Kimberly A Cradock; Z George Liu; Partha S Ray; Stephen A Boppart
Journal:  BMC Cancer       Date:  2016-02-23       Impact factor: 4.430

7.  Anatomically correct visualization of the human upper airway using a high-speed long range optical coherence tomography system with an integrated positioning sensor.

Authors:  Joseph C Jing; Lidek Chou; Erica Su; Brian J F Wong; Zhongping Chen
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

Review 8.  Acquisition, Visualization and Potential Applications of 3D Data in Anatomic Pathology.

Authors:  Shyam Prajapati; Emilio Madrigal; Mark T Friedman
Journal:  Discoveries (Craiova)       Date:  2016-12-31

9.  Optimal endobronchial tool sizes for targeting lung lesions based on 3D modeling.

Authors:  Torre M Bydlon; Gerrit C Langhout; Ferry Lalezari; Koen J Hartemink; Jasper Nijkamp; Susan G Brouwer de Koning; Sjaak Burgers; Benno H W Hendriks; Theodoor J M Ruers
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

10.  Label-free pathology by spectrally sliced femtosecond stimulated Raman scattering (SRS) microscopy.

Authors:  Andrew Francis; Kyla Berry; Yikai Chen; Benjamin Figueroa; Dan Fu
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.